Andersen Eric's Form 4 filing
Merrimack Pharmaceuticals Inc (MACK) · filed Mar 22, 2023
- Accession no.
- 0000950170-23-009171
- Filed
- Mar 22, 2023, 4:06 PM ET
- Trade date
- Mar 21, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.85M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andersen EricCIK 0001517667 | Director, Other: See remarks |
| Western Standard Partners LPCIK 0001450414 | Other: See Remarks |
| Western Standard LLCCIK 0001517666 | Other: See Remarks |
| Western Standard Partners QP, L.P.CIK 0001544857 | Other: See Remarks |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 21, 2023 | Common Stock | PPurchaseAcquired | +127,409 | $11.52 | +$1,467,751.68 | 1,412,044 | Indirect | |
| Mar 21, 2023 | Common Stock | PPurchaseAcquired | +33,181 | $11.52 | +$382,245.12 | 357,514 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.